Search results
Clinicians should recommend against using cannabis or cannabinoids as a cancer-directed treatment unless within the context of a clinical trial. Cannabis and/or cannabinoids may improve refractory, chemotherapy-induced nausea and vomiting when added to guideline-concordant antiemetic regimens.
- Cannabis Use in Patients With Cancer: A Clinical Review
Several studies support the efficacy of cannabis for various...
- Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A
Adults with cancer using cannabis or cannabinoids should...
- Cannabis Use in Patients With Cancer: A Clinical Review
24 cze 2022 · Several studies support the efficacy of cannabis for various cancer and treatment-related symptoms, such as chemotherapy-induced nausea and cancer pain.
20 maj 2022 · A promising substitute for opioid-based medication is medical cannabis (MC). However, there is a knowledge gap in the study of cannabis, especially for treating cancer-related pain, and results are controversial.
22 lut 2022 · To assess the efficacy, tolerability and safety of cannabis‐based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer.
13 mar 2024 · Adults with cancer using cannabis or cannabinoids should understand that the clinical evidence to support their use as cancer-directed therapy in humans is lacking.
27 mar 2023 · Medicinal marijuana is a medication currently undergoing research for its use in the management and treatment of several oncology-related symptoms. Such areas of potential use include chemotherapy-induced nausea, vomiting, analgesia, cachexia, and tumor suppression.
5 cze 2023 · Objectives: To evaluate the benefits and harms of cannabis-based medicines, including medical cannabis, for treating pain and other symptoms in adults with cancer compared to placebo or any other established analgesic for cancer pain. Search methods: We used standard, extensive Cochrane search methods. The latest search date was 26 January 2023.
